| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Restricted cash | 0 | |||
| Prepaid expenses and other current assets | 2,684 | |||
| Marketable securities | 73,657 | |||
| Cash and cash equivalents | 30,649 | |||
| Total current assets | 106,990 | |||
| Property, plant and equipment, net | 0 | |||
| Other non-current assets | 0 | |||
| Operating lease right-of-use assets | 0 | |||
| Total assets | 106,990 | |||
| Accrued liabilities | 3,662 | |||
| Lease liabilities | 0 | |||
| Deferred revenue | 0 | |||
| Accounts payable | 2,398 | |||
| Total current liabilities | 6,060 | |||
| Other liabilities, non-current | 0 | |||
| Lease liabilities, non-current | 0 | |||
| Deferred revenue, non-current | 0 | |||
| Total liabilities | 6,060 | |||
| Accumulated deficit | -972,345 | |||
| Common stock, value-Nonvoting Common Stock | 254 | |||
| Common stock, value-Common Stock Class Undefined | 347 | |||
| Additional paid-in-capital | 1,072,666 | |||
| Accumulated other comprehensive income | 8 | |||
| Total stockholders' equity | 100,930 | |||
| Total liabilities and stockholders' equity | 106,990 | |||
IGM Biosciences, Inc. (IGMS)
IGM Biosciences, Inc. (IGMS)